MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2

NIH Pandemic-Era Grants

Pandemic Era Grants

2020

↗ Live URL (may be dead)

Document text

Principal Investigator: TIMOTHY  STEDMAN
Organization: AMERICAN TYPE CULTURE COLLECTION
Fiscal Year: 2020
Award: $4,101,590
Funding agency: National Institute of Allergy and Infectious Diseases

This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and reference reagents to the research community. These reagents span the pathogens in the Division of Microbiology and Infectious Diseases portfolio, and include the National Institutes of Allergy and Infectious Disease (NIAID) Category A, B and C Priority Pathogens and emerging infectious diseases.

Terms: <2019 novel coronavirus><2019-nCoV><Basic Research><Basic Science><COVID-19><COVID19><Categories><Communicable Diseases><Communities><Contracting Opportunities><Contracts><Development and Research><Emerging Communicable Diseases><Emerging Infectious Diseases><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Microbiology><NIAID><National Institute of Allergy and Infectious Disease><Production><R & D><R&D><Reagent><Research><Research Resources><Resources><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe acute respiratory syndrome coronavirus 2><Wuhan coronavirus><biological research><corona virus disease 2019><coronavirus disease 2019><depository><pathogen><preservation><priority pathogen><product development><repository><research and development>